市場調査レポート

商品コード

1741414

結膜炎市場：疾患タイプ別、投与経路別、薬剤クラス別、流通チャネル別、地域別

Eye Flu (Conjunctivitis) Market, By Disease Type, By Route of Administration, By Drug Class, By Distribution Channel, By Geography

出版日: 2025年03月27日
発行: Coherent Market Insights
ページ情報: 英文 170 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 653,040円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,015,840円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,451,200円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.12円

全表示
概要
目次

概要

サンプル依頼リストに入れる

結膜炎市場は、2025年には52億9,000万米ドルと推定され、2032年には90億7,000万米ドルに達する見込みで、2025年から2032年までのCAGRで8％の成長が予測されています。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	52億9,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	8.00%	2032年の価値予測	90億7,000万米ドル

結膜炎は、世界中で数百万人が罹患する一般的な眼感染症です。結膜炎は、白目の部分を覆い、まぶたの内側を覆っている薄い透明な層である結膜の炎症が特徴です。この症状は、ウイルスや細菌感染、アレルギー、刺激物など様々な要因によって引き起こされます。

世界の結膜炎市場は競争が激しく、複数の主要企業が業界を支配しています。Novartis AG、Allergan、Bausch Health、Santen Pharmaceutical、Johnson & Johnson、Alembic Pharmaceuticalsなどがこの市場の主要企業です。これらの企業は、点眼薬、軟膏、内服薬など、幅広い製品と治療を提供しています。

市場力学：

世界の結膜炎市場の成長は、眼感染症の有病率の増加、眼の健康に対する意識の高まり、医療技術の進歩など、いくつかの要因によって牽引されています。老年人口の増加、アレルギーや刺激物の発生率の増加も市場成長に寄与しています。

しかし、世界の結膜炎市場の成長を阻害する要因もあります。治療費の高さ、発展途上地域における医療施設へのアクセスの制限、代替治療の利用可能性などです。また、厳しい規制要件や特定の薬剤に伴う副作用のリスクといった課題にも直面しています。

こうした課題にもかかわらず、世界の結膜炎市場には多くの成長機会があります。効果的で安全な治療法に対する需要の高まり、革新的な製品の開発、新興経済諸国における医療インフラの拡充などが、近い将来の市場成長の原動力になると予想されます。

本調査の主な特徴

本レポートでは、2024年を基準年として、2025～2032年の予測期間における市場規模やCAGRなど、世界の結膜炎市場を詳細に分析しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
本レポートからの洞察により、企業のマーケティング担当者や経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができるようになります。
世界の結膜炎市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の結膜炎市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Novartis AG
Allergan
Bausch Health
Santen Pharmaceutical
Johnson & Johnson
Alembic Pharmaceuticals
Akorn Pharmaceuticals
Alcon
Pfizer
Valeant Pharmaceuticals
Merck & Co.
Similasan Corporation
Sun Pharmaceutical Industries
Prestige Consumer Healthcare
Lupin Pharmaceuticals
Alembic Pharmaceuticals
Aurolab
Intas Pharmaceuticals
Sun Pharma
Cipla

第11章セクション

調査手法
出版社について

Product Code: CMI6211

Eye Flu (Conjunctivitis) Market is estimated to be valued at USD 5.29 Bn in 2025 and is expected to reach USD 9.07 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 5.29 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.00%	2032 Value Projection:	USD 9.07 Bn

Eye flu, also known as conjunctivitis, is a common eye infection that affects millions of people worldwide. It is characterized by inflammation of the conjunctiva, the thin, transparent layer that covers the white part of the eye and lines the inner surface of the eyelids. This condition can be caused by various factors including viral or bacterial infections, allergies, or irritants.

Global eye flu (conjunctivitis) market is highly competitive, with several key players dominating the industry. Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, and Alembic Pharmaceuticals are some of the leading companies in this market. These companies offer a wide range of products and treatments for eye flu including eye drops, ointments, and oral medications.

Market Dynamics:

Global eye flu (conjunctivitis) market growth is driven by several factors including the increasing prevalence of eye infections, growing awareness about eye health, and advancements in medical technology. Rising geriatric population and increasing incidence of allergies and irritants also contributes to the market growth.

However, there are certain restraints that may hinder growth of the global eye flu (conjunctivitis) market. These include the high cost of treatment, limited access to healthcare facilities in developing regions, and the availability of alternative treatments. The market faces challenges such as stringent regulatory requirements and the risk of adverse effects associated with certain medications.

Despite these challenges, the global eye flu (conjunctivitis) market presents numerous opportunities for growth. Increasing demand for effective and safe treatments, the development of innovative products, and the expansion of healthcare infrastructure in emerging economies are expected to drive the market growth in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global eye flu (conjunctivitis) market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key companies covered as a part of this study include Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, Alembic Pharmaceuticals, Akorn Pharmaceuticals, Alcon, Pfizer, Valeant Pharmaceuticals, Merck & Co., Similasan Corporation, Sun Pharmaceutical Industries, Prestige Consumer Healthcare, Lupin Pharmaceuticals, Alembic Pharmaceuticals, Aurolab, Intas Pharmaceuticals, Sun Pharma, and Cipla
Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global eye flu (conjunctivitis) market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye flu (conjunctivitis) market

Detailed Segmentation:

By Disease Type
- Viral Conjunctivitis
- Bacterial Conjunctivitis
- Allergic Conjunctivitis
- Chemical Conjunctivitis
- Others
By Route of Administration
- Topical
- Oral
- Intravenous
By Drug Class
- Antibiotics
- Anti-allergy
- Anti-inflammatories
- Combination
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Novartis AG
- Allergan
- Bausch Health
- Santen Pharmaceutical
- Johnson & Johnson
- Alembic Pharmaceuticals
- Akorn Pharmaceuticals
- Alcon
- Pfizer
- Valeant Pharmaceuticals
- Merck & Co.
- Similasan Corporation
- Sun Pharmaceutical Industries
- Prestige Consumer Healthcare
- Lupin Pharmaceuticals
- Alembic Pharmaceuticals
- Aurolab
- Intas Pharmaceuticals
- Sun Pharma
- Cipla

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Disease Type
- Market Snippet, By Route of Administration
- Market Snippet, By Drug Class
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Eye Flu (Conjunctivitis) Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Eye Flu (Conjunctivitis) Market, By Disease Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Viral Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Bacterial Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Allergic Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Chemical Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Eye Flu (Conjunctivitis) Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Eye Flu (Conjunctivitis) Market, By Drug Class, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Anti-allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Anti-inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Combination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Eye Flu (Conjunctivitis) Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Eye Flu (Conjunctivitis) Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Allergan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bausch Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Santen Pharmaceutical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Alembic Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Akorn Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Alcon
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Valeant Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Similasan Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Prestige Consumer Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Lupin Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Alembic Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Aurolab
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Intas Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sun Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cipla
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

結膜炎市場：疾患タイプ別、投与経路別、薬剤クラス別、流通チャネル別、地域別

Eye Flu (Conjunctivitis) Market, By Disease Type, By Route of Administration, By Drug Class, By Distribution Channel, By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の結膜炎市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章世界の結膜炎市場、疾患タイプ別、2020年～2032年

第6章世界の結膜炎市場、投与経路別、2020年～2032年

第7章世界の結膜炎市場、薬剤クラス別、2020年～2032年

第8章世界の結膜炎市場、流通チャネル別、2020年～2032年

第9章世界の結膜炎市場、地域別、2020年～2032年

第10章競合情勢

第11章セクション

Market Dynamics:

Key Features of the Study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Eye Flu (Conjunctivitis) Market- Impact of Coronavirus (COVID-19) Pandemic

5. Global Eye Flu (Conjunctivitis) Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Eye Flu (Conjunctivitis) Market, By Route of Administration, 2020-2032, (US$ Bn)

7. Global Eye Flu (Conjunctivitis) Market, By Drug Class, 2020-2032, (US$ Bn)

8. Global Eye Flu (Conjunctivitis) Market, By Distribution Channel, 2020-2032, (US$ Bn)

9. Global Eye Flu (Conjunctivitis) Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

結膜炎市場：疾患タイプ別、投与経路別、薬剤クラス別、流通チャネル別、地域別

Eye Flu (Conjunctivitis) Market, By Disease Type, By Route of Administration, By Drug Class, By Distribution Channel, By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の結膜炎市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章 世界の結膜炎市場、疾患タイプ別、2020年～2032年

第6章 世界の結膜炎市場、投与経路別、2020年～2032年

第7章 世界の結膜炎市場、薬剤クラス別、2020年～2032年

第8章 世界の結膜炎市場、流通チャネル別、2020年～2032年

第9章 世界の結膜炎市場、地域別、2020年～2032年

第10章 競合情勢

第11章 セクション

Market Dynamics:

Key Features of the Study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Eye Flu (Conjunctivitis) Market- Impact of Coronavirus (COVID-19) Pandemic

5. Global Eye Flu (Conjunctivitis) Market, By Disease Type, 2020-2032, (US$ Bn)

6. Global Eye Flu (Conjunctivitis) Market, By Route of Administration, 2020-2032, (US$ Bn)

7. Global Eye Flu (Conjunctivitis) Market, By Drug Class, 2020-2032, (US$ Bn)

8. Global Eye Flu (Conjunctivitis) Market, By Distribution Channel, 2020-2032, (US$ Bn)

9. Global Eye Flu (Conjunctivitis) Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の結膜炎市場 - コロナウイルス（COVID-19）パンデミックの影響

第5章世界の結膜炎市場、疾患タイプ別、2020年～2032年

第6章世界の結膜炎市場、投与経路別、2020年～2032年

第7章世界の結膜炎市場、薬剤クラス別、2020年～2032年

第8章世界の結膜炎市場、流通チャネル別、2020年～2032年

第9章世界の結膜炎市場、地域別、2020年～2032年

第10章競合情勢

第11章セクション